Does the copper intrauterine device affect serum cancer antigen 125 levels?

Purpose: This study aimed to reveal the effect of the copper IUD, if any, on serum CA-125 levels in patients who use the device as a contraceptive.

Methods: Blood samples were obtained two times from 20 healthy volunteers before and after IUD insertion, and sera were isolated. The sera, centrifuged at 2000 G and kept at -70 degrees C in a deep freezer until analyzed, were processed for CA-125 levels by the CA-125 kit using VIDAS PC analyzer (Biomerieux, France) and results were compared.

Results: The CA-125 level of the serum obtained from the first blood samples was significantly higher than that of the second sample (24.63 +/- 25.40 mIU/ml and 14.44 +/- 10.08 mIU/ml, respectively) (p < 0.05).

Conclusion: The results of this study indicate that the serum level of CA-125 may be lower in patients using copper IUDs which may be helpful in evaluation of ovarian masses in women in reproductive age.

CA-125; Copper IUD

[1] Jacobs I.J., Menon U.: "Progress and challenges in screening for early detection of ovarian cancer". Mal. Cell. Proteornics., 2004, 3,355.

[2] Obeidat B.R.,A marin Z.O.,L atimer J.A.,C rawford R.A.: "Risk of malignancy index in the preoperative evaluation of pelvic masses" Int. J. Gynaecol. Obstet., 2004, 85, 255.

[3] Gocmen A., Karaca M., Tarakcioglu M.: "A ruptured ovanan endometrioma mimicking ovarian malignancy". Eur. J. Gynaecol. Oneal., 2003, 4, 445.

[4] Niloff J.M., Knapp R.C., Schaetzl E., Reynolds C., Bast R.C "CA-125 serum levels in obstetrics and gynecology". Obstet Gynecol., 1984, 64, 703.

[5] Avaliable at URL: http://www.popcouncil.org.

[6] Bahamondes L., Faundes A., Sobreira-Lima B., Lui-Filho J.F., Pecci P., Matera S.: "TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age". Contraception, 2005, 72, 337.

[7] de Sa Rosa e Silva A.C., Rosa e Silva J.C., Nogueira A.A., Petta C.A., Abrao M.S., Ferriani R.A.: "The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis". Fertil. Steril., 2006, 86, 742.

[8] Finkler N.J., Benecerrat B., Lavin P., Wojciechowski C., Knapp R.C.: "Comparison of serum CA-125, clinical impression and ultrasound in the preoperative evaluation of ovarian masses". Obstet. Gynecol., 1988, 72, 659.

[9] Kato H., Hatori M., Watanabe M., Kokobun S.: "Epithelioid sar comas with elevated serum CAl25: report of two cases". Jpn. J. Clin. Oncol., 2003, 33, 141.

[10] Turk H.M., Pekdemir H., Buyukberber S., Sevinc A., Camci C., Kocabas R. et al.: "Serum CA-125 levels in patients with chronic heart failure and accompanying pleural fluid". Tumour Biol., 2003, 24, 172.

[11] Karaca M., Gocmen A., Sari A., Ugur M.G.: "Effect of hysterosalpingography on serum cancer antigen (CA-125) levels". Eur. J. Gynaecol. Oncol., 2005, 26, 203.